Genetics of hemangiomas, vascular malformations, and primary lymphedema

Julie Blatt, Cynthia M. Powell, Craig N. Burkhart, Joseph Stavas, Arthur S. Aylsworth

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

With improved genetic testing and genomic sequencing, abnormalities are increasingly being identified in affected or germline tissues in DNA of patients with vascular tumors, vascular malformations, and lymphedema. Recognition of the genetics of vascular anomalies should help clinicians make more specific diagnoses, anticipate diagnosis-specific morbidities, provide better genetic counseling, and have a better understanding of the pathogenesis of these anomalies. Growing pharmacologic options, including therapies targeted to specific mutations, with obvious parallels to cancer treatment now allow the pediatric hematologistoncologist to assume a more prominent role in clinical care and research for patients with these diagnoses. We summarize genes and genetic loci that have been associated with vascular anomalies and offer guidelines for patient evaluations.

Original languageEnglish
Pages (from-to)587-593
Number of pages7
JournalJournal of Pediatric Hematology/Oncology
Volume36
Issue number8
StatePublished - Nov 8 2014
Externally publishedYes

Fingerprint

Vascular Malformations
Lymphedema
Hemangioma
Blood Vessels
Genetic Loci
Genetic Counseling
Genetic Testing
Neoplasms
Patient Care
Guidelines
Pediatrics
Morbidity
Mutation
DNA
Therapeutics
Research
Genes

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology
  • Medicine(all)

Cite this

Blatt, J., Powell, C. M., Burkhart, C. N., Stavas, J., & Aylsworth, A. S. (2014). Genetics of hemangiomas, vascular malformations, and primary lymphedema. Journal of Pediatric Hematology/Oncology, 36(8), 587-593.

Genetics of hemangiomas, vascular malformations, and primary lymphedema. / Blatt, Julie; Powell, Cynthia M.; Burkhart, Craig N.; Stavas, Joseph; Aylsworth, Arthur S.

In: Journal of Pediatric Hematology/Oncology, Vol. 36, No. 8, 08.11.2014, p. 587-593.

Research output: Contribution to journalReview article

Blatt, J, Powell, CM, Burkhart, CN, Stavas, J & Aylsworth, AS 2014, 'Genetics of hemangiomas, vascular malformations, and primary lymphedema', Journal of Pediatric Hematology/Oncology, vol. 36, no. 8, pp. 587-593.
Blatt, Julie ; Powell, Cynthia M. ; Burkhart, Craig N. ; Stavas, Joseph ; Aylsworth, Arthur S. / Genetics of hemangiomas, vascular malformations, and primary lymphedema. In: Journal of Pediatric Hematology/Oncology. 2014 ; Vol. 36, No. 8. pp. 587-593.
@article{460374b45c0040e8a4b440c23e822182,
title = "Genetics of hemangiomas, vascular malformations, and primary lymphedema",
abstract = "With improved genetic testing and genomic sequencing, abnormalities are increasingly being identified in affected or germline tissues in DNA of patients with vascular tumors, vascular malformations, and lymphedema. Recognition of the genetics of vascular anomalies should help clinicians make more specific diagnoses, anticipate diagnosis-specific morbidities, provide better genetic counseling, and have a better understanding of the pathogenesis of these anomalies. Growing pharmacologic options, including therapies targeted to specific mutations, with obvious parallels to cancer treatment now allow the pediatric hematologistoncologist to assume a more prominent role in clinical care and research for patients with these diagnoses. We summarize genes and genetic loci that have been associated with vascular anomalies and offer guidelines for patient evaluations.",
author = "Julie Blatt and Powell, {Cynthia M.} and Burkhart, {Craig N.} and Joseph Stavas and Aylsworth, {Arthur S.}",
year = "2014",
month = "11",
day = "8",
language = "English",
volume = "36",
pages = "587--593",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Genetics of hemangiomas, vascular malformations, and primary lymphedema

AU - Blatt, Julie

AU - Powell, Cynthia M.

AU - Burkhart, Craig N.

AU - Stavas, Joseph

AU - Aylsworth, Arthur S.

PY - 2014/11/8

Y1 - 2014/11/8

N2 - With improved genetic testing and genomic sequencing, abnormalities are increasingly being identified in affected or germline tissues in DNA of patients with vascular tumors, vascular malformations, and lymphedema. Recognition of the genetics of vascular anomalies should help clinicians make more specific diagnoses, anticipate diagnosis-specific morbidities, provide better genetic counseling, and have a better understanding of the pathogenesis of these anomalies. Growing pharmacologic options, including therapies targeted to specific mutations, with obvious parallels to cancer treatment now allow the pediatric hematologistoncologist to assume a more prominent role in clinical care and research for patients with these diagnoses. We summarize genes and genetic loci that have been associated with vascular anomalies and offer guidelines for patient evaluations.

AB - With improved genetic testing and genomic sequencing, abnormalities are increasingly being identified in affected or germline tissues in DNA of patients with vascular tumors, vascular malformations, and lymphedema. Recognition of the genetics of vascular anomalies should help clinicians make more specific diagnoses, anticipate diagnosis-specific morbidities, provide better genetic counseling, and have a better understanding of the pathogenesis of these anomalies. Growing pharmacologic options, including therapies targeted to specific mutations, with obvious parallels to cancer treatment now allow the pediatric hematologistoncologist to assume a more prominent role in clinical care and research for patients with these diagnoses. We summarize genes and genetic loci that have been associated with vascular anomalies and offer guidelines for patient evaluations.

UR - http://www.scopus.com/inward/record.url?scp=84918563110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918563110&partnerID=8YFLogxK

M3 - Review article

VL - 36

SP - 587

EP - 593

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 8

ER -